Abstract
Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 are members of the carnitine system, which are responsible of the regulation of the mitochondrial CoA/acyl-CoA ratio and of supplying substrates for the ß-oxidation to mitochondria. This study, using cross-Linking reagent, Blue native electrophoresis and immunoprecipitation followed by detection with immunoblotting, shows conclusive evidence about the interaction between carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase supporting the channeling of acylcarnitines and carnitine at level of the inner mitochondrial membrane.
Avoid common mistakes on your manuscript.
Introduction
Fatty acids represent metabolic energy source for many tissues in particular muscle ones [1, 2]; moreover, several evidences support that fatty acids oxidation is also performed in nervous system [3, 4]. Fatty acids are oxidized by the β-oxidation pathway, which is realized by enzymes localized into the mitochondrial matrix or in peroxisomes [5, 6]. As first step of mitochondrial fatty acids catabolism they must be converted to acyl-CoA thioesters by action of the long-chain acyl-CoA synthetase (ACSL) which is localized in the cytosol [7]. Then, the fatty acyl-CoA can cross the outer mitochondrial membrane through the voltage-dependent anion channel (VDAC) but not the inner membrane due to the lack of a specific transporter. The carnitine palmitoyltransferase-1a (CPT-1a), an integral outer mitochondrial membrane protein, catalyzes the trans-esterification of the fatty acyl groups from CoA to carnitine with production of acylcarnitines that, from the cytosol, are released into the intermembrane space [2]. It has been recently demonstrated that CPT-1a, ACSL, and VDAC form an outer membrane complex that channels fatty acyl groups through the outer mitochondrial membrane [8]. Acylcarnitines, are then translocated by the carnitine/acylcarnitine translocase (CACT), localized on the inner mitochondrial membrane, into the mitochondrial matrix where carnitine palmitoyltransferase 2 (CPT-2) catalyzes the reverse reaction transferring the acyl groups from carnitine to mitochondrial CoA, thereby providing substrates for ß-oxidation. Thus the carnitine shuttle system operates the fatty acids transfer from cytosolic to matrix CoA. The CACT belongs to the mitochondrial carrier family, sharing all the distinctive properties of this protein family and catalyzes both acylcarnitines exchange with free carnitine according to an antiport mechanism and unidirectional transport of acylcarnitines [9–12]. This translocase has been well characterized concerning its function and structure/function relationships using the proteoliposome experimental model together with site-directed mutagenesis, chemical labeling and bioinformatics [13–15]. CPT-2 has been studied at molecular level since a 1.6 Å resolution structure of the full length enzyme has been obtained and a structure of CPT-2 in complex with the generic CPT inhibitor ST1326, a substrate analogue mimicking palmitoylcarnitine, was solved at 2.5 Å resolution [16, 17]. Interestingly, CPT-2 and CACT share some structural features such as charged residues and hydrophobic domains involved in the substrate binding, [15, 18, 19], suggesting that very similar energy of interaction may occur among the two proteins and acylcarnitines. This common structure relationships suggest the idea that acylcarnitines could be channeled from the translocase to the enzyme thus facilitating the sequences of reactions essential for accomplishing the oxidation of the fatty acids coming from the cytosol. Very recently, a novel function was proposed for CPT-2 and CACT, a reverse activity of the carnitine shuttle responsible of acylcarnitines export under condition of acyl-CoA excess [20] so that acylcarnitines channeling has to be considered also on the opposite direction. Using combined experimental approaches, we have demonstrated that CPT-2 and CACT interact forming a supramolecular complex in the inner mitochondrial membrane with the obvious function of channeling acylcarnitines.
Materials and methods
SDS-PAGE and western blot analysis
SDS-PAGE electrophoresis was performed in the presence of 0.1 % SDS according to Laemmli [21]. Minigel system, sizes 8 cm × 10 cm × 0.75 mm, was used. Stacking gel and separation gel 5 and 17.5 % acrylamide, respectively, (acrylamide/bisacrylamide ratio 30:0.2) were used. Proteins were transferred to nitrocellulose membrane (Schleicher and Schuell, PROTRAN BA 85 cellulosenitrat). Residual binding sites on the membrane were blocked by incubation with 3 % BSA in buffer composed of 150 mM NaCl, 50 mM Tris–HCl, 0.05 % Tween20 pH 7.5, for 10 min and then incubated with a rabbit polyclonal anti-CACT (dilution 1:1.000) or anti-CPT-2 from Abnova (dilution 1:1.000)in 0.5 % BSA solution for 1 h at room temperature (RT). The anti-CACT antibodies were produced in our laboratory resulting specific both against rat and human CACT [4, 22]. The specificity of both antibodies in the experimental condition used has been tested, Fig. 1.
Blue native electrophoresis (BNE) and second-dimension electrophoresis
BNE was performed as references [23, 24] and is briefly summarized below. Mitoplasts (0.4 mg) were washed with BNE buffer containing 0.75 mM aminocaproic acid, 50 mM Bis–Tris (Sigma-Aldrich). The pellet was resuspended in BNE buffer with digitonin or DDM (Sigma-Aldrich) at detergent/protein ratio of six, kept on ice for 30 min, mixed every 5 min, and centrifuged at 16.000 × g for 30 min. Proteases inhibitor, 1 mM PMSF (Sigma-Aldrich), and Coomassie blue G-250 (BIO-RAD) in a detergent/dye ratio of 8 were added to the supernatant. The protein complexes were separated on a 6–13 % gradient acrylamide gel. Each lane was cut out of the BNE gel and incubated in SDS denaturation buffer. The lanes were turned 90° and loaded onto the top of SDS-PAGE acrylamide gel to perform a second-dimension electrophoresis. Proteins were transferred onto PVDF membrane (Immobilon-P PVDF Transfer Membrane EMD Millipore) and immunodecorated with anti-CACT antibodies. The spot corresponding to CACT was detected as in Sect. 2.1. PVDF membrane was then subjected to stripping, i.e., the removal of primary and secondary antibodies from the western blot membrane by incubation with 1 % SDS, 25 mM Glycine at pH 2 for 25 min. The membrane was then washed 3 times with 150 mM NaCl, 50 mM Tris–HCl pH 7.5 and immune-decorated with anti-CPT-2 antibodies. The corresponding spots were detected as previous described.
Immunoprecipitation with anti-CACT
CACT antibodies (diluted in the PBS buffer 1:500) was incubated with Protein G agarose beads (KPL) for 2 h at 4 °C. Mitoplasts were solubilized with PBS/digitonin buffer at detergent/protein ratio of 6 and centrifuged at 16.000×g for 30 min. The supernatant was incubated overnight at 4 °C on gently rock with the pre-conjugated Protein G agarose/anti-CACT. Beads were then collected by centrifugation and washed five times with solubilization buffer. To take the immuno-precipitated proteins off the Protein G, the beads were resuspended in 2X Laemmli buffer and boiled for 5 min. SDS-PAGE and western blot analysis were then performed.
Formaldehyde cross-linking
Mitoplasts were obtained from freshly prepared rat liver mitochondria at a concentration of 10 mg/ml [25]. Aliquots of 0.4 mg mitoplasts preparation were pelleted in 1.5 ml reaction tube and resuspended in PBS. Mitoplasts were then centrifuged and resuspended in PBS (control) or PBS and formaldehyde (Sigma-Aldrich) at a final concentration of 0.5 or 1 %. The incubation was performed at RT for 7 min. Mitoplasts were then centrifuged at 1.800×g for 3 min. The supernatant was removed and the formaldehyde reaction quenched mixing the pellet with 0.25 mM glycine. Mitoplasts were then washed with PBS and solubilized in Laemmli buffer. After SDS-PAGE, onto a 8 % acrylamide gel (acrylamide/bisacrylamide ratio 30:0.2), western blot analysis was performed.
Results
Protein complex revealed by BNE
Rat liver mitoplasts were treated either with digitonin or DDM, with at a detergent/protein ratio, respectively, of 6 and 2.5, to achieve membrane protein complex extraction. The protein extracts were subjected to BNE, which is mild enough to keep intact protein–protein interactions. The lanes containing the mitoplasts extracts obtained either with digitonin or DDM were subjected to a second electrophoresis separation under denaturing conditions in the presence of SDS (Figs. 2a, 3a). After transferring onto a PVDF membrane, immunostaining of both CACT and CPT-2 has been performed. The membrane was first immunodecorated with anti-CACT, Figs. 2b and 3b, and after stripping, with anti-CPT-2 antibodies, Figs. 2c and 3c. Figures 2d and 3d show the superimposition of the immunostaining with the two different antibodies. After treatment of the mitoplasts with digitonin (Fig. 2d) only spots located in the same vertical lane, related to CACT or CPT-2, appeared indicating that in the first BNE run these proteins were totally associated. After solubilization of mitoplasts with DDM, some spots were observed which were not located in the same vertical line, indicating that a fraction of the protein complex was dissociated by DDM treatment.
Co-immunoprecipitation of CPT-2 and CACT
The two approaches described above, i.e.,formaldehyde cross-linking and BNE, suggested that CPT-2 and CACT are functionally associated at the inner mitochondrial membrane level. Antibody against CACT protein was used to test whether CPT-2 can co-immunoprecipitate with CACT. In Fig. 4a, an immunodecorated band was detected at about 65 kDa after immunoprecipitation (IP) corresponding to the CPT-2 identified in the solubilized mitoplasts. No immunostaining was observed in the flow-through or in the beads supernatant not incubated with solubilized mitoplasts. Analogously, after stripping and immunostaining with the anti-CACT an immunostained band at about 30 kDa was observed after immunoprecipitation in Fig. 4b, which corresponded to the CACT immunostained in the mitoplast extract. Also in this case no immunostaining was observed in the control lines. As a negative control, the presence in the immunoprecipitate of oxoglutarate carrier, that is a member of the mitochondrial carrier proteins and has similar molecular weight of CACT, was tested. No reaction was detected using anti-oxoglutarate carrier antibody from Sigma (not shown). The co-immunoprecipitation approach confirmed the association of CACT and CPT-2.
Formaldehyde cross-link of complex forming proteins
Mitoplasts, obtained from rat liver mitochondria, were treated with formaldehyde which is known to cross-link close proteins [26]. Immunodecoration of the treated mitoplasts with anti-CACT (Fig. 5a) revealed, besides a band at about 30 kDa corresponding to CACT monomer, also a band at 93 kDa which was more evident at higher formaldehyde concentration. Similarly after staining with the anti CPT-2 (Fig. 5b), the same band at 93 kDa was revealed, besides the band at 66 kDa corresponding to CPT-2 monomer. The untreated sample showed only the single bands, respectively, at about 30 and 66 kDa (Fig. 5a, b).
Discussion
In this study, an interaction between CACT and CPT-2, devoted to the formation of a supramolecular complex, has been demonstrated. A protein complex has also been revealed in BNE experiments performed either with digitonin or with DDM. Digitonin has been previously used to study mitochondrial electron transport chain complexes and super-complexes [27, 28] and the subunits composition of outer membrane mitochondrial protein translocase TOM 22 [29, 30] such as DDM to isolate mitochondrial respiratory supercomplex I-III [31]. CACT and CPT-2 were observed exclusively as complex after mitoplasts digitonin solubilization while, after treatment with DDM, also CACT and CPT-2 monomers were observed (Fig. 2, 3). These data indicate that in native membranes CACT and CPT-2 form a supramolecular complex. After treatment with DDM part of the complex was disrupted probably due to DDM stronger delipidating properties, suggesting a possible involvement of lipids in the protein–protein interaction. It is well documented that CACT has an essential requirement for cardiolipin, which is a specific phospholipid of the inner mitochondrial membrane [9, 13, 32, 33]. Moreover, it has been previously suggested that cardiolipin interacts with Cys 58 of the CACT [34] located in the first hydrophilic loop (loop h1-2) of the translocator, protruding toward the matrix [19]. It is not possible to establish the molecular nature of CACT/CPT-2 association, i.e., if there is a direct protein–protein interaction or a connection through a lipid adaptor or both of them, indeed we argue a possible role of cardiolipin in the complex forming. Cardiolipin is crucial for substrate channeling in supercomplex of the mitochondrial respiratory chain [35, 36] and for defining ADT/ATP carrier interactome [37]. In the previously proposed model of membrane association of CPT-2, the 30 amino acids loop (Asn179-Asn208) binds the IMM both by hydrophobic residues, that submerge into the core of the membrane, and by positively charged residues, that facilitate association with the polar hydrophilic head-groups of cardiolipin molecules of IMM [17]. CACT matrix loop h12, that contains Cys58, is constituted by several hydrophobic and basic amino acids disposed along all the loop as evident in Fig. 6. We postulate that the CPT-2 binding membrane loop and the CACT loop h12 do interact with IMM in a similar way binding vicinal cardiolipin molecules and membrane core [16, 17, 34, 38].
The interaction between the two proteins has been further demonstrated by the immuno-precipitation procedure that confirmed the existence of the CACT/CPT-2 complex as evident in Fig. 4. Formaldehyde, which is one of the shortest available cross-linkers with a spacer arm length of 2.3–2.7 Å and is highly permeable toward cell membranes, allowed the stabilization, from rat liver mitoplasts, of a protein complex containing both CACT and CPT-2, as revealed by immunodecoration with anti-CPT-2 and anti-CACT (Fig. 5). The demonstrated interaction between CACT and CPT-2 devoted to the fatty acids translocation through the inner mitochondrial membrane is in line with the grooving evidences of substrates channeling involved in several metabolic pathways [39–42] and in particular is consistent with Lee et al. [8] who established strong protein–protein interaction between CPT1a, ACSL, and VDAC that forms a supramolecular complex engaged in activated fatty acids transfer through the mitochondrial outer membrane. Channeling of acylcarnitines substrates from CACT into the active site of the receiving enzyme CPT-2 has been hypothesized by Rufer et al. [43]. Fraser and Zammit evidence that CACT and CPT-2 are located both at the contact sites level and in the inner mitochondrial membrane [44] and, later, also Hoppel et al. [45] demonstrated that CACT and CPT-2 are co-expressed in both contact sites and IMM . We argue that the acylcarnitine channeling can function also in the opposite direction since CACT catalyzes acylcarnitines exit from mitochondria according to Violante et al. [20] and to Madiraju et al. [46], who, respectively, evidenced that CACT deficiency compromises mitochondrial export of acylcarnitines, and that acetylcarnitine export from mitochondria supplies acetyl groups for histone acetylation. Our conclusions are also supported by Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database of physical and functional interactions [47]. As evident in Fig. 7a, the predicted protein interactions of CACT (Slc25a20) show that it interacts mostly with CPT1 and CPT-2 (three lines connecting the enzymes and in particular the black one that represents the co-expression of the proteins). When the clustering algorithm KMEANS is used with more stringent values, the cluster CACT/CPT-2 still remains, Fig. 7b, thus confirming that this protein–protein interaction is the most confident among the ones in which CACT is involved. [http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/software.htm (KMEANS implementation)] [48]. The results here reported give new information on a crucial step of fatty acids oxidation highlighting the existence of a supramolecular complex involved in the carnitine network [49] aimed at evident acylcarnitine channeling.
Abbreviations
- DTE:
-
Dithioerythritol
- NEM:
-
N–Ethylmaleimide
- CACT:
-
Carnitine/acylcarnitine translocase
- CPT-1a:
-
Carnitine palmitoyltransferase 1a
- CPT-2:
-
Carnitine palmitoyltransferase 2
- DDM:
-
n-Dodecyl-ß-d-maltopyranoside
- ACSL:
-
Long-chain acyl-CoA synthetase
- VDAC:
-
Voltage-dependent anion channel
- BNE:
-
Blue native electrophoresis
References
Zammit VA, Ramsay RR, Bonomini M, Arduini A (2009) Carnitine, mitochondrial function and therapy. Adv Drug Deliv Rev 61:1353–1362. doi:10.1016/j.addr.2009.04.024
McGarry JD, Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1–14
Nałecz KA, Miecz D, Berezowski V, Cecchelli R (2004) Carnitine: transport and physiological functions in the brain. Mol Aspects Med 25:551–567. doi:10.1016/j.mam.2004.06.001
Tonazzi A, Mantovani C, Colella M, Terenghi G, Indiveri C (2013) Localization of mitochondrial carnitine/acylcarnitine translocase in sensory neurons from rat dorsal root Ganglia. Neurochem Res 38:2535–2541. doi:10.1007/s11064-013-1168-z
Ramsay RR (1999) The role of the carnitine system in peroxisomal fatty acid oxidation. Am J Med Sci 318:28–35
Ramsay RR, Gandour RD, van der Leij FR (2001) Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 1546:21–43
Bhuiyan J, Pritchard PH, Pande SV, Seccombe DW (1995) Effects of high-fat diet and fasting on levels of acyl-coenzyme A binding protein in liver, kidney, and heart of rat. Metabolism 44:1185–1189
Lee K, Kerner J, Hoppel CL (2011) Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J Biol Chem 286:25655–25662. doi:10.1074/jbc.M111.228692
Indiveri C, Tonazzi A, Palmieri F (1990) Identification and purification of the carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1020:81–86
Indiveri C, Tonazzi A, Palmieri F (1994) The reconstituted carnitine carrier from rat liver mitochondria: evidence for a transport mechanism different from that of the other mitochondrial translocators. Biochim Biophys Acta 1189:65–73
Indiveri C, Tonazzi A, Palmieri F (1991) Characterization of the unidirectional transport of carnitine catalyzed by the reconstituted carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1069:110–116
Palmieri F (2013) The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med 34:465–484. doi:10.1016/j.mam.2012.05.005
Indiveri C, Iacobazzi V, Giangregorio N, Palmieri F (1998) Bacterial overexpression, purification, and reconstitution of the carnitine/acylcarnitine carrier from rat liver mitochondria. Biochem Biophys Res Commun 249:589–594. doi:10.1006/bbrc.1998.9197
De Lucas JR, Indiveri C, Tonazzi A, Perez P, Giangregorio N, Iacobazzi V, Palmieri F (2008) Functional characterization of residues within the carnitine/acylcarnitine translocase RX2PANAAXF distinct motif. Mol Membr Biol 25:152–163. doi:10.1080/09687680701697476
Giangregorio N, Tonazzi A, Console L, Indiveri C, Palmieri F (2010) Site-directed mutagenesis of charged amino acids of the human mitochondrial carnitine/acylcarnitine carrier: insight into the molecular mechanism of transport. Biochim Biophys Acta 1797:839–845. doi:10.1016/j.bbabio.2010.03.017
Hsiao YS, Jogl G, Esser V, Tong L (2006) Crystal structure of rat carnitine palmitoyltransferase II (CPT-II). Biochem Biophys Res Commun 346:974–980. doi:10.1016/j.bbrc.2006.06.006
Rufer AC, Lomize A, Benz J, Chomienne O, Thoma R, Hennig M (2007) Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog. FEBS Lett 581:3247–3252. doi:10.1016/j.febslet.2007.05.080
Tonazzi A, Console L, Giangregorio N, Indiveri C, Palmieri F (2012) Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups. Biochim Biophys Acta 1817:697–704. doi:10.1016/j.bbabio.2012.02.007
Tonazzi A, Giangregorio N, Indiveri C, Palmieri F (2009) Site-directed mutagenesis of the His residues of the rat mitochondrial carnitine/acylcarnitine carrier: implications for the role of His-29 in the transport pathway. Biochim Biophys Acta 1787:1009–1015. doi:10.1016/j.bbabio.2009.02.026
Violante S, Ijlst L, Te Brinke H, Tavares de Almeida I, Wanders RJ, Ventura FV, Houten SM (2013) Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines. FASEB J 27:2039–2044. doi:10.1096/fj.12-216689
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Huizing M, Iacobazzi V, Ijlst L, Savelkoul P, Ruitenbeek W, van den Heuvel L, Indiveri C, Smeitink J, Trijbels F, Wanders R, Palmieri F (1997) Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 61:1239–1245. doi:10.1086/301628
Schägger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199:223–231
Wittig I, Braun HP, Schägger H (2006) Blue native PAGE. Nat Protoc 1:418–428. doi:10.1038/nprot.2006.62
Indiveri C, Tonazzi A, Palmieri F (1992) Identification and purification of the ornithine/citrulline carrier from rat liver mitochondria. Eur J Biochem 207:449–454
Klockenbusch C, Kast J (2010) Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1. J Biomed Biotechnol 2010:927585. doi:10.1155/2010/927585
Schägger H (2001) Blue-native gels to isolate protein complexes from mitochondria. Methods Cell Biol 65:231–244. doi:10.1016/0005-2736(91)90235-Z
Schägger H (1995) Native electrophoresis for isolation of mitochondrial oxidative phosphorylation protein complexes. Methods Enzymol 260:190–202
Nakamura Y, Suzuki H, Sakaguchi M, Mihara K (2004) Targeting and assembly of rat mitochondrial translocase of outer membrane 22 (TOM22) into the TOM complex. J Biol Chem 279:21223–21232. doi:10.1074/jbc.M314156200
Werhahn W, Niemeyer A, Jänsch L, Kruft V, Schmitz UK, Braun H (2001) Purification and characterization of the preprotein translocase of the outer mitochondrial membrane from Arabidopsis. Identification of multiple forms of TOM20. Plant Physiol 125:943–954
Schägger H, Pfeiffer K (2000) Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J 19:1777–1783. doi:10.1093/emboj/19.8.1777
Noël H, Pande SV (1986) An essential requirement of cardiolipin for mitochondrial carnitine acylcarnitine translocase activity. Lipid requirement of carnitine acylcarnitine translocase. Eur J Biochem 155:99–102
Indiveri C, Tonazzi A, Prezioso G, Palmieri F (1991) Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1065:231–238. doi:10.1016/0005-2736(91)90235-Z
Giangregorio N, Tonazzi A, Indiveri C, Palmieri F (2007) Conformation-dependent accessibility of Cys-136 and Cys-155 of the mitochondrial rat carnitine/acylcarnitine carrier to membrane-impermeable SH reagents. Biochim Biophys Acta 1767:1331–1339. doi:10.1016/j.bbabio.2007.08.010
Zhang M, Mileykovskaya E, Dowhan W (2002) Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277:43553–43556. doi:10.1074/jbc.C200551200
Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, Schägger H (2003) Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278:52873–52880. doi:10.1074/jbc.M308366200
Claypool SM (2009) Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788:2059–2068. doi:10.1016/j.bbamem.2009.04.020
Kashfi K, Mynatt RL, Park EA, Cook GA (2011) Membrane microenvironment regulation of carnitine palmitoyltranferases I and II. Biochem Soc Trans 39:833–837. doi:10.1042/BST0390833
Wang Y, Mohsen AW, Mihalik SJ, Goetzman ES, Vockley J (2010) Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes. J Biol Chem 285:29834–29841. doi:10.1074/jbc.M110.139493
Vélot C, Srere PA (2000) Reversible transdominant inhibition of a metabolic pathway. In vivo evidence of interaction between two sequential tricarboxylic acid cycle enzymes in yeast. J Biol Chem 275:12926–12933
Lenaz G, Baracca A, Barbero G, Bergamini C, Dalmonte ME, Del Sole M, Faccioli M, Falasca A, Fato R, Genova ML, Sgarbi G, Solaini G (2010) Mitochondrial respiratory chain super-complex I-III in physiology and pathology. Biochim Biophys Acta 1797:633–640. doi:10.1016/j.bbabio.2010.01.025
Yao KW, Schulz H (1996) Intermediate channeling on the trifunctional beta-oxidation complex from pig heart mitochondria. J Biol Chem 271:17816–17820
Rufer AC, Thoma R, Hennig M (2009) Structural insight into function and regulation of carnitine palmitoyltransferase. Cell Mol Life Sci 66:2489–2501. doi:10.1007/s00018-009-0035-1
Fraser F, Zammit VA (1999) Submitochondrial and subcellular distributions of the carnitine-acylcarnitine carrier. FEBS Lett 445:41–44
Hoppel C, Kerner J, Turkaly P, Tandler B (2001) Rat liver mitochondrial contact sites and carnitine palmitoyltransferase-I. Arch Biochem Biophys 392:321–325. doi:10.1006/abbi.2001.2463
Madiraju P, Pande SV, Prentki M, Madiraju SR (2009) Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 4:399–403
Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ (2013) STRING v9.1: protein–protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41:D808–D815. doi:10.1093/nar/gks1094
Brohée S, van Helden J (2006) Evaluation of clustering algorithms for protein–protein interaction networks. BMC Bioinformatics 7:488. doi:10.1186/1471-2105-7-488
Indiveri C, Pochini L, Oppedisano F, Tonazzi A (2010) The Carnitine Transporter Network: interactions with Drugs. Curr Chem Biol 4:108–123
Declaration of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Console, L., Giangregorio, N., Indiveri, C. et al. Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane. Mol Cell Biochem 394, 307–314 (2014). https://doi.org/10.1007/s11010-014-2098-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-014-2098-z